Who has invested in Millendo Therapeutics?

NEA, Roche are named among the investors backing Millendo Therapeutics.

Millendo Therapeutics Funding: $118M Raised, Series B (2026)

Millendo Therapeutics funding overview

Millendo Therapeutics is based in Half Moon Bay, California. Millendo Therapeutics has raised $118M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in July 2026. The round record for Millendo Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include NEA, Roche. 2 distinct backers are named across the disclosed rounds.

Millendo Therapeutics at a glance

Total raised: $118M
Latest round: Series B
Latest round date: July 2026
Headquarters: Half Moon Bay, California
Notable investors: NEA, Roche

Frequently asked about Millendo Therapeutics funding

How much has Millendo Therapeutics raised?: Millendo Therapeutics has raised $118M in total disclosed funding across the rounds on record.
Who has invested in Millendo Therapeutics?: NEA, Roche are named among the investors backing Millendo Therapeutics.
What was the latest Millendo Therapeutics funding round?: The most recent disclosed round is a Series B, announced in July 2026.
Where is Millendo Therapeutics based?: Millendo Therapeutics is based in Half Moon Bay, California.
When did Millendo Therapeutics last raise?: The last disclosed Millendo Therapeutics round closed in July 2026 at Series B.

Round data for Millendo Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Half Moon Bay and backer lists below.

Millendo Therapeutics Funding: $118M Raised, Series B (2026)

Millendo Therapeutics funding overview

Millendo Therapeutics at a glance

Frequently asked about Millendo Therapeutics funding

Companies related to Millendo Therapeutics (18)

Browse related funding lists (3)